SporeGen® enters a collaborative joint venture with Nam Khoa Biotech, Vietnam

  • October 20, 2016
  • SporeGen

SporeGen® has entered into a collaborative venture with Nam Khoa Biotech, Ho Chi Minh City, Vietnam. Nam Khoa Biotech is the leading diagnostic company in Vietnam and possibly SE Asia and has a large portfolio of diagnostic kits in the market. SporeGen® will be working with Nam Khoa Biotech on a number of innovative projects relating to diagnostics and novel therapeutics relevant to human gastrointestinal pathogens.